2/20/2014 9:09:13 AM
SAN ANTONIO--(BUSINESS WIRE)--ViroXis Corporation today announced that the final patient has completed treatment in its Phase 2 clinical study of the Company’s East Indian Sandalwood Oil (EISO) based therapy for HPV/common skin warts. Efficacy and safety results will be known once the data is analyzed in April following a three-month follow-up period.
Help employers find you! Check out all the jobs and post your resume.
comments powered by